These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38355180)

  • 21. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
    Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
    BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.
    Radcliffe E; Servin R; Cox N; Lim S; Tan QY; Howard C; Sheikh C; Rutter P; Latter S; Lown M; Brad L; Fraser SDS; Bradbury K; Roberts HC; Saucedo AR; Ibrahim K
    BMC Geriatr; 2023 Sep; 23(1):591. PubMed ID: 37743469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
    JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method.
    Brisnik V; Vukas J; Jung-Sievers C; Lukaschek K; Alexander GC; Thiem U; Thürmann P; Schüle C; Fischer S; Baum E; Drey M; Harder S; Niebling W; Janka U; Krause O; Gensichen J; Dreischulte T;
    BMC Med; 2024 May; 22(1):193. PubMed ID: 38735930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial.
    Sharp DJ; Chew-Graham C; Tylee A; Lewis G; Howard L; Anderson I; Abel K; Turner KM; Hollinghurst SP; Tallon D; McCarthy A; Peters TJ
    Health Technol Assess; 2010 Sep; 14(43):iii-iv, ix-xi, 1-153. PubMed ID: 20860888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
    McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
    JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review.
    Turk A; Wong G; Mahtani KR; Maden M; Hill R; Ranson E; Wallace E; Krska J; Mangin D; Byng R; Lasserson D; Reeve J
    BMC Med; 2022 Aug; 20(1):297. PubMed ID: 36042454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.
    Niznik J; Ferreri SP; Armistead L; Urick B; Vest MH; Zhao L; Hughes T; McBride JM; Busby-Whitehead J
    Trials; 2022 Apr; 23(1):256. PubMed ID: 35379307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
    Omuya H; Nickel C; Wilson P; Chewning B
    Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pharmacist integrated into a general practice in Australia: an evolving model of care in medicines optimization.
    Jordan M; Mullan J; Stewart A; Chen TF
    Int J Pharm Pract; 2023 Dec; 31(6):608-616. PubMed ID: 37823732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting.
    Ó Ciardha D; Blake AM; Creane D; Callaghan MÓ; Darker C
    BMJ Open; 2022 May; 12(5):e050261. PubMed ID: 35623753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial.
    Zechmann S; Senn O; Valeri F; Essig S; Merlo C; Rosemann T; Neuner-Jehle S
    BMC Geriatr; 2020 Nov; 20(1):471. PubMed ID: 33198634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term antidepressant use in general practice: a qualitative study of GPs' views on discontinuation.
    Donald M; Partanen R; Sharman L; Lynch J; Dingle GA; Haslam C; van Driel M
    Br J Gen Pract; 2021 Jul; 71(708):e508-e516. PubMed ID: 33875415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.
    Saya S; Chondros P; Abela A; Mihalopolous C; Chatterton ML; Gunn J; Chen TF; Polasek TM; Dettmann E; Brooks R; King M; Spencer L; Alphonse P; Milton S; Ramsay G; Siviour Z; Liew J; Ly P; Thoenig M; Seychell R; La Rocca F; Hesson LB; Mejias N; Sivertsen T; Galea MA; Bousman C; Emery J
    Trials; 2023 May; 24(1):342. PubMed ID: 37208772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Weffald LA; Green AR; Reeve E; Maciejewski ML; Sheehan OC; Wolff JL; Kraus C; Boyd CM
    JAMA Intern Med; 2022 May; 182(5):534-542. PubMed ID: 35343999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices.
    Hassan D; Versmissen J; Hek K; van Dijk L; van den Bemt PMLA
    BMC Prim Care; 2022 Nov; 23(1):280. PubMed ID: 36352363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.